| American college of cardiology 57th scientific sessions, 2008. | |
| | |
MedLine Citation:
|
PMID: 19561793 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The peak-interest clinical trials at the American College of Cardiology (ACC) Scientific Sessions, which took place from March 29 to April 2, 2008, are generally ushered into the high-profile Late-Breaking Clinical Trials sessions. This year, the ENHANCE trial (Effect of Combination Ezetimibe and High-Dose Simvastatin vs. Simvastatin Alone on the Atherosclerotic Process in Patients with Heterozygous Familial Hypercholesterolemia) was precluded from the "Late-Breakers" because a peek at the unexpectedly disappointing data had already been afforded in January.Amid pre-meeting publicity about allegedly inappropriate data delays (and a Congressional hearing delving into them), the ACC created a special plenary session "Showcase" presentation of the data with a review panel for comment. The ENHANCE findings intensified interest in both non-lipid-lowering benefits of statins and non-statins for lipid lowering. This 57th ACC conference hosted a record 29,000 attendees in Chicago, Illinois. |
| | |
Authors:
|
Reuben B David |
Related Documents
:
|
10302703 - Does policy match practice? a new college survey shows where healthcare executives scor... 19430713 - Hotline sessions presented at the american college of cardiology congress 2009. 10823993 - The false claims act. an interview with mark kleiman. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: P & T : a peer-reviewed journal for formulary management Volume: 33 ISSN: 1052-1372 ISO Abbreviation: P T Publication Date: 2008 May |
Date Detail:
|
Created Date: 2009-06-29 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9015516 Medline TA: P T Country: United States |
Other Details:
|
Languages: eng Pagination: 296-8 Citation Subset: - |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of Persistence with Drug Therapy On the Risk of Myocardial Re-infarction.
Next Document: Pharmaceutical approval update.